AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PROTECTIONS OF HEALTHCARE PROVIDERS ACT

2026 Regular Session Introduced by Jake Bissaillon and 9 co-sponsors

Allows medication abortion prescription labels to show the prescribing practice’s name instead of the individual clinician’s name.

06/05/2026 Referred to House Judiciary

Summary of SB 2033 (Rhode Island) – 2026

Purpose and intent

This bill adds a prescriptive protection related to medication abortion drugs under the Rhode Island Protections for Healthcare Providers Act.

Specifically, it allows the prescription label for medication abortion prescription drugs to show the name of the dispensing healthcare practice (e.g., the clinic or practice) rather than the individual dispenser’s name.

Key provisions

Section amended: Chapter 5-37.8 of the General Laws, “Protections for Healthcare Providers Act.”

New provision: 5-37.8-4. Prescriptive protections for providers of legal protected healthcare activity.

(a) The prescription label for medication abortion prescription drugs may include the name of the dispensing healthcare practice instead of the name of the dispenser.
(b) Defines “medication abortion prescription drugs” as substances used to medically terminate a pregnancy, including but not limited to mifepristone and misoprostol.

Effective date: The act takes effect upon passage.

Who/what is affected

Affects patients receiving medication abortion prescriptions and the dispensing entities (healthcare practices/clinics) that dispense such medications.

Affects how prescription labels identify the source of the medication (practice name vs. individual clinician/dispenser name).

Procedural and timeline aspects

Legislative status:

Introduced January 9, 2026.
Referred to Senate Health & Human Services.
Committee recommendation: held for further study (March 3, 2026).
Scheduled for consideration (June 2, 2026) as of the latest action.

Effective date: Immediately upon passage if enacted.

Potential impact and considerations

Privacy/branding: Allows clinics to list the practice name on medication abortion prescriptions, which may affect patient privacy, provider identification, and clinic branding.

Administrative: Simplifies labeling in cases where multiple clinicians within a practice may dispense the same medication.

Access and interpretation: The policy aligns labeling with practice identity, which could influence how patients or pharmacies view dispensing sources.

Legal/ethical context: The provision is described as a “prescriptive protection,” consistent with protections for healthcare providers acting within legal boundaries related to abortion care.

Bill